Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 9
Results: 30
Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1933, doi. 10.1038/leu.2013.90
- By:
- Publication type:
- Article
Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1943, doi. 10.1038/leu.2013.179
- By:
- Publication type:
- Article
Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1910, doi. 10.1038/leu.2013.64
- By:
- Publication type:
- Article
RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1793, doi. 10.1038/leu.2013.200
- By:
- Publication type:
- Article
Suppression of Pu.1 function results in expanded myelopoiesis in zebrafish.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1913, doi. 10.1038/leu.2013.67
- By:
- Publication type:
- Article
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1813, doi. 10.1038/leu.2013.140
- By:
- Publication type:
- Article
Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1940, doi. 10.1038/leu.2013.144
- By:
- Publication type:
- Article
Mutations and prognosis in primary myelofibrosis.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1861, doi. 10.1038/leu.2013.119
- By:
- Publication type:
- Article
AKT is a therapeutic target in myeloproliferative neoplasms.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1882, doi. 10.1038/leu.2013.167
- By:
- Publication type:
- Article
CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1870, doi. 10.1038/leu.2013.122
- By:
- Publication type:
- Article
Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1936, doi. 10.1038/leu.2013.92
- By:
- Publication type:
- Article
Age, JAK2<sup>V617F</sup> and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1826, doi. 10.1038/leu.2013.120
- By:
- Publication type:
- Article
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1920, doi. 10.1038/leu.2013.79
- By:
- Publication type:
- Article
Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1926, doi. 10.1038/leu.2013.82
- By:
- Publication type:
- Article
Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1930, doi. 10.1038/leu.2013.85
- By:
- Publication type:
- Article
Nilotinib treatment-associated accelerated atherosclerosis: when is the risk justified?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1939, doi. 10.1038/leu.2013.112
- By:
- Publication type:
- Article
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1874, doi. 10.1038/leu.2013.163
- By:
- Publication type:
- Article
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1852, doi. 10.1038/leu.2013.133
- By:
- Publication type:
- Article
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1949, doi. 10.1038/leu.2013.190
- By:
- Publication type:
- Article
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1917, doi. 10.1038/leu.2013.77
- By:
- Publication type:
- Article
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1803, doi. 10.1038/leu.2013.173
- By:
- Publication type:
- Article
Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1923, doi. 10.1038/leu.2013.81
- By:
- Publication type:
- Article
Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1841, doi. 10.1038/leu.2013.193
- By:
- Publication type:
- Article
Mobilization studies in C3-deficient mice unravel the involvement of a novel crosstalk between the coagulation and complement cascades in mobilization of hematopoietic stem/progenitor cells.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1928, doi. 10.1038/leu.2013.84
- By:
- Publication type:
- Article
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1891, doi. 10.1038/leu.2013.186
- By:
- Publication type:
- Article
Toll-like receptor alterations in myelodysplastic syndrome.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1832, doi. 10.1038/leu.2013.180
- By:
- Publication type:
- Article
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1902, doi. 10.1038/leu.2013.95
- By:
- Publication type:
- Article
Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1820, doi. 10.1038/leu.2013.117
- By:
- Publication type:
- Article
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 9, p. 1946, doi. 10.1038/leu.2013.182
- By:
- Publication type:
- Article